 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - EyePoint Pharmaceuticals Inc. (EYPT)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-14 Purchase | 2019-11-18 08:42 am | EyePoint Pharmaceuticals Inc. | EYPT | Elston George CFO | 10,000 | $1.429 | $14,290 | 745,000 (Direct) | View |
| 2019-05-13 Purchase | 2019-05-15 4:55 pm | EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director | 40,000 | $1.74 | $69,600 | 40,000 (Direct) | View |
| 2019-04-01 Purchase | 2019-04-03 08:25 am | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 5,000 | $1.89 | $9,450 | 17,500 (Direct) | View |
| 2019-03-29 Purchase | 2019-04-01 08:23 am | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 28,500 | $1.763 | $50,246 | 240,200 (Direct) | View |
| 2019-03-29 Purchase | 2019-04-01 08:20 am | EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director | 17,000 | $1.752 | $29,784 | 29,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-14 Option Award | 2019-11-18 08:42 am | N/A 2029-11-14 | EyePoint Pharmaceuticals Inc. | EYPT | Elston George CFO | 745,000 | $1.42 | 745,000 (Direct) | View |
| 2019-10-12 Tax Withholding | 2019-10-15 6:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 10,745 | $2.105 | 314,455 (Direct) | View |
| 2019-10-12 Tax Withholding | 2019-10-15 6:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 2,450 | $2.105 | 43,047 (Direct) | View |
| 2019-10-09 Exercise | 2019-10-11 6:13 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 33,333 | $1.95 | 200,083 (Direct) | View |
| 2019-10-09 Exercise | 2019-10-11 6:13 pm | 2019-06-21 2028-06-21 | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 33,333 | $1.95 | 200,083 (Direct) | View |
| 2019-09-06 Exercise | 2019-09-10 08:46 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 417 | $0 | 166,750 (Direct) | View |
| 2019-09-06 Exercise | 2019-09-10 08:46 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 417 | $0 | 166,750 (Direct) | View |
| 2019-07-15 Option Award | 2019-07-16 4:39 pm | N/A 2029-07-15 | EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director | 80,000 | $1.51 | 80,000 (Direct) | View |
| 2019-06-27 Exercise | 2019-06-28 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 6,667 | $0 | 92,005 (Direct) | View |
| 2019-06-27 Tax Withholding | 2019-06-28 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 1,961 | $1.65 | 92,005 (Direct) | View |
| 2019-06-27 Exercise | 2019-06-28 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 6,667 | $0 | 92,005 (Direct) | View |
| 2019-06-27 Exercise | 2019-06-28 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 10,000 | $0 | 48,437 (Direct) | View |
| 2019-06-27 Tax Withholding | 2019-06-28 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 2,940 | $1.65 | 48,437 (Direct) | View |
| 2019-06-27 Exercise | 2019-06-28 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 10,000 | $0 | 48,437 (Direct) | View |
| 2019-06-27 Exercise | 2019-06-28 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 40,000 | $0 | 325,200 (Direct) | View |
| 2019-06-27 Exercise | 2019-06-28 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 40,000 | $0 | 325,200 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:53 pm | 2019-06-25 2020-06-25 | EyePoint Pharmaceuticals Inc. | EYPT | ROGERS MICHAEL W Director | 40,000 | $2.65 | 40,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:52 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 40,000 | $2.65 | 40,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:52 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 40,000 | $2.65 | 40,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:51 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director | 40,000 | $2.65 | 40,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:51 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director | 40,000 | $2.65 | 40,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:51 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Peterson Kristine Director | 40,000 | $2.65 | 40,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:50 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director | 50,000 | $2.65 | 50,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 411,523 | $0 | 930,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:50 pm | N/A 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 930,000 | $2.65 | 930,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:49 pm | N/A 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Price David CFO | 300,000 | $2.65 | 300,000 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:48 pm | N/A 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 370,000 | $2.65 | 370,000 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:31 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | ROGERS MICHAEL W Director | 6,667 | $0 | 119,167 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:31 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | ROGERS MICHAEL W Director | 6,667 | $0 | 119,167 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:30 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 8,333 | $0 | 166,333 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:30 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 8,333 | $0 | 166,333 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:29 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Peterson Kristine Director | 6,667 | $0 | 6,667 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:29 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Peterson Kristine Director | 6,667 | $0 | 6,667 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:29 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director | 6,667 | $0 | 36,167 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:29 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director | 6,667 | $0 | 36,167 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 6,667 | $0 | 44,167 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 6,667 | $0 | 44,167 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-17 5:42 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 45,000 | $0 | 285,200 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-17 5:42 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 45,000 | $0 | 285,200 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-17 5:41 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 8,280 | $0 | 87,732 (Direct) | View |
| 2019-06-14 Tax Withholding | 2019-06-17 5:41 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 2,394 | $1.53 | 87,732 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-17 5:41 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 8,280 | $0 | 87,732 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-17 5:40 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 14,200 | $0 | 42,612 (Direct) | View |
| 2019-06-14 Tax Withholding | 2019-06-17 5:40 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 4,175 | $1.53 | 42,612 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-17 5:40 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 14,200 | $0 | 42,612 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-12 4:38 pm | N/A 2029-06-10 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 350,000 | $1.47 | 350,000 (Direct) | View |
| 2019-04-12 Exercise | 2019-04-16 08:16 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 20,000 | $1.77 | 37,500 (Direct) | View |
| 2019-04-12 Exercise | 2019-04-16 08:16 am | 2018-06-27 2027-06-27 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 20,000 | $1.77 | 37,500 (Direct) | View |
| 2019-04-01 Exercise | 2019-04-02 08:24 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 5,000 | $1.81 | 79,452 (Direct) | View |
| 2019-04-01 Exercise | 2019-04-02 08:24 am | N/A 2019-06-25 | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 5,000 | $1.81 | 79,452 (Direct) | View |
| 2019-03-29 Exercise | 2019-04-01 08:21 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 20,000 | $1.77 | 158,000 (Direct) | View |
| 2019-03-29 Exercise | 2019-04-01 08:21 am | 2018-06-27 2027-06-27 | EyePoint Pharmaceuticals Inc. | EYPT | Mazzo David J Director | 20,000 | $1.77 | 158,000 (Direct) | View |
| 2019-03-19 Tax Withholding | 2019-03-21 5:24 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 1,188 | $2.47 | 28,412 (Direct) | View |
| 2019-03-19 Tax Withholding | 2019-03-21 5:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 1,735 | $2.47 | 74,452 (Direct) | View |
| 2019-01-25 Option Award | 2019-01-29 4:08 pm | N/A 2029-01-25 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 80,000 | $2.42 | 80,000 (Direct) | View |
| 2018-12-22 Exercise | 2018-12-26 4:06 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 62,892 | $0 | 94,709 (Direct) | View |
| 2018-12-22 Tax Withholding | 2018-12-26 4:06 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 18,522 | $1.65 | 94,709 (Direct) | View |
| 2018-12-22 Exercise | 2018-12-26 4:06 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ross Leonard S See Remarks | 62,892 | $0 | 94,709 (Direct) | View |
| 2018-11-15 Exercise | 2018-11-16 4:00 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | ROGERS MICHAEL W Director | 100,000 | $1.13 | 112,500 (Direct) | View |
| 2018-11-15 Exercise | 2018-11-16 4:00 pm | 2009-11-18 2018-11-18 | EyePoint Pharmaceuticals Inc. | EYPT | ROGERS MICHAEL W Director | 100,000 | $1.13 | 112,500 (Direct) | View |
| © 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 Tue, 19 Nov 2019 10:09:44 -0600 | SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |